Establishing the next level of eye care
iCare (icare-world.com) scores 77 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 53rd percentile of 9853 Healthcare brands.
iCare is a company specializing in eye diagnostics solutions, founded in 2005. It is recognized as the original developer of rebound tonometry, producing compact, easy-to-use diagnostic devices for detecting glaucoma, diabetic retinopathy, and macular degeneration. Following its merger with Visionix, iCare expanded into a broader provider of turnkey eye care solutions, covering imaging, refraction, OCT, and connected workflow software. Its target audience includes ophthalmologists, optometrists, and other healthcare providers seeking reliable diagnostic tools for ocular diseases.
| Brand Name | iCare |
|---|---|
| Domain | icare-world.com |
| Industry | Healthcare, Technology |
| Founded | 2005 |
| Main Competitors | Topcon, Nidek (74/100), Carl Zeiss Meditec (84/100), Heidelberg Engineering (60/100), Reichert Technologies, Haag-Streit (74/100), Optovue |
Moz Domain Authority 34/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #3,016,152 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Eye diagnostics solutions" (Meta description too short (3 words). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt mentions GPTBot, ChatGPT-User, ClaudeBot, Google-Extended, PerplexityBot - all allowed - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: PHP, Nginx, WordPress, Ghost.
Social footprint: verified profiles on YouTube, X (Twitter), Facebook, Instagram, GitHub; no detected presence on LinkedIn - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is iCare?", Claude could identify the brand as of September 2026. iCare is a Finland-based medical device company known for its handheld and home-use rebound tonometers that measure intraocular pressure without anesthesia, widely used in glaucoma screening and monitoring. Best known for Rebound tonometers (like the icare ic100 and icare HOME) for measuring eye pressure without needing anesthetic drops.
When asked "Best brands similar to iCare?", Claude would recommend iCare as of September 2026. It's a well-established, respected name in ophthalmic diagnostic devices, so I'd mention it if someone asked about leading tonometry or glaucoma monitoring brands.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
iCare's main competitors in Healthcare: Nidek (74/100), Carl Zeiss Meditec (84/100), Heidelberg Engineering (60/100), Haag-Streit (74/100).
Sources: Brand Analyzer scan
iCare has limited AI-search visibility, scoring 39/100 on Brand Analyzer's AI visibility composite (visibility 23, trust 51, recommendation 54). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: iCare official site
iCare was founded in 2005. iCare operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
iCare scores 54/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: iCare official site
iCare can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: iCare official site
iCare offers diagnostic tools for glaucoma, diabetic retinopathy, and macular degeneration, centered on its rebound tonometry technology for measuring intraocular pressure. Following its merger with Visionix, the company's portfolio expanded to include imaging systems, refraction devices, optical coherence tomography (OCT), and connected workflow software, forming a comprehensive suite of turnkey eye care solutions for clinical use.
Sources: iCare official site
iCare is a company that develops eye diagnostics solutions, founded in 2005. It is best known as the original developer of rebound tonometry, a technique used to measure intraocular pressure. After merging with Visionix, iCare grew into a broader eye care solutions provider offering diagnostic and imaging technology for ophthalmic conditions such as glaucoma, diabetic retinopathy, and macular degeneration.
Sources: iCare official site
iCare designs and manufactures diagnostic devices and software for eye care professionals. Its core technology, rebound tonometry, allows fast and easy measurement of intraocular pressure, which is critical for detecting and monitoring glaucoma. Through its merger with Visionix, the company also provides imaging, refraction, and OCT (optical coherence tomography) tools, along with connected workflow software, forming a comprehensive suite of ophthalmic diagnostic solutions for clinics and hospitals.
Sources: iCare official site
iCare is known for being the original developer of rebound tonometry, a method for measuring intraocular pressure that is fast, easy to use, and does not require anesthesia. This innovation has made it a recognized name in glaucoma diagnostics. Following its merger with Visionix, iCare has also become known for offering a broader turnkey portfolio of eye care diagnostic and imaging technologies.
Sources: iCare official site
iCare's products are used by eye care physicians, ophthalmologists, optometrists, and other healthcare providers who require reliable diagnostic and imaging tools for detecting and monitoring ocular diseases such as glaucoma, diabetic retinopathy, and macular degeneration.
Sources: iCare official site
iCare scores 39/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
iCare has a weak AI-visibility profile at 39/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (54/100) and its weakest is visibility (23/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #3,016,152 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 34/100 and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify iCare from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to iCare: Hybrent (77/100), Hunter's Hope (77/100), IHSCM (Institute of Health and Social Care Management) (77/100), Improve Veterinary Education (77/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.